Intrapartum Monitoring Devices Market

Intrapartum Monitoring Devices Market Outlook (2022 to 2032)

The global intrapartum monitoring devices market was valued at US$ 2.2 Billion in 2021, and is projected to register a Y-o-Y increase of 4.5% in 2022 to be valued at US$ 2.3 Billion. During the 2022 to 2032 period of assessment, demand is expected to rise at a 6.8% value CAGR, likely to reach US$ 4.5 Billion by the end of the said forecast period.

Report Attributes	Details
Anticipated Base Year Value (2021)	US$ 2.2 Billion
Expected Market Value (2022)	US$ 2.3 Billion
Projected Forecast Value (2032)	US$ 4.5 Billion
Global Growth Rate (2022 to 2032)	6.8% CAGR
Growth Rate of the U.S (2022 to 2032)	6.6% CAGR
Expected Market Value of China (2032)	US$ 324.0 Million
Dollar Opportunity in Japan (2022 to 2032)	US$ 103.7 Million
Key Intrapartum Monitoring Devices Providers	Analogic Corporation; GE Healthcare; Koninklijke Philips N.V.; Medtronic plc.; CooperSurgical, Inc.; Stryker; Olympus Corporation; Cardinal Health; MindChild Medical

Overall, the intrapartum monitoring devices market is poised to yield an absolute dollar opportunity worth US$ 2.2 Billion until 2032. Sales of electrode product types will continue to flourish, with a documented CAGR of 7.4% from 2015-2021. Moreover, North America will remain at the forefront, generating an opportunity worth US$ 1.6 Billion during the forecast period.

Intrapartum Monitoring Devices Market Revenue Analysis 2015 to 2021 vs. Future Outlook 2022 to 2032

Increasing advancements in technologies have prompted Intrapartum Monitoring Devices providers to transform services to a whole new level. As per market research and competitive intelligence provider Fact.MR, the market for intrapartum monitoring devices witnessed a staggering 7.5% CAGR from 2015 to 2021.

Consistent up-gradation of an intrapartum monitoring system to provide a seamless user experience is the need of the hour. By incorporating avant-garde breakthroughs, service providers are not only able to reduce operational costs, but also enhance their returns on investment. The intrapartum monitoring system market is likely to benefit from technological advancements and product innovation in the field of intrapartum monitoring devices.

Furthermore, changing compliance and governance requirements are also widening the scope of the intrapartum monitoring devices market whether it is to migrate, transform or build, deploying the right application strategy can work miracles. From 2022 to 2032, the Intrapartum Monitoring Devices market is forecast to grow 1.9x.

Prominent Intrapartum Monitoring Devices Industry Growth Drivers

Advancements in Fetal and Maternal Care to widen Intrapartum Monitoring Devices Uptake

The market is expected to exhibit the fastest growth rate over the forecast period, owing to the demand for improved maternal care and the increasing rate of premature birth complications . The rise in expenditure on healthcare in developing countries and growth in patient awareness of the use of intrapartum monitoring devices provide new opportunities for the market players.

Awareness regarding the clinical benefits of monitoring devices drives the sales of the Intrapartum Monitoring Devices market in the forecasting period.

Increasing risks and complications such as brain damage, cerebral palsy, newborn seizures, or fetal death during childbirth drive the growth of the market. In addition, the complications related to preterm birth, intrapartum events such as birth asphyxia, or infections such as sepsis or pneumonia account for newborn deaths fuels the growth of the intrapartum monitoring devices market.

Key Challenges Prevalent in the Global Intrapartum Monitoring Devices Market

High Costs associated with Monitoring Devices may Impede Growth

The intrapartum monitoring devices market is likely to benefit from technological advancements and product innovation in the field of fetal and maternal health monitoring fuels the growth of the market on the other hand high cost associated with surgical procedures may hinder the growth of the market.

One of the limiting factors which hinder the growth of intrapartum monitoring devices market is rising concern about radiation from monitors that can have an impact on patients’ health. Moreover, the lack of qualified obstetric professionals in developing countries will limit the intrapartum monitoring market growth in the coming years.

However, low awareness of the use of intrapartum devices is expected toper the market growth. The increasing adoption of out-of-hospital births is expected to be major restraining factor for growth of the market.

Country-wise Analysis

What is the Growth Outlook for Intrapartum Monitoring Devices in the U.S?

An Evolving Healthcare Sector increasing Demand

According to Fact.MR, demand for intrapartum monitoring devices in the U.S is likely to expand at a 6.6% value CAGR until 2032, forecast to yield an opportunity worth US$ 755.4 Million. Demand is further expected to be valued at US$ 1.6 Billion by the end of the said forecast period. Growth is attributed to the increasing prevalence of gynecological diabetes mellitus, and growing cases of obesity in women.

As women suffering from gynecological diabetes mellitus are also prone to intrapartum issues and preterm deliveries. Emerging as the pinnacle of global technological advancement in healthcare departments, the US is likely to present highly attractive growth opportunities for intrapartum monitoring device providers in the long–run.

Growth is attributed to the large patient population for target diseases, the strong presence of device manufacturers in the region, and the availability of significant R&D investments to support intrapartum system development.

The U.S continues to hold a leading share in the global intrapartum monitoring devices market, primarily fuelled by the increasing use of intrapartum monitoring devices in the healthcare sector owing to the developed healthcare system. The presence of many established players in the region shows the highest growth in the intrapartum monitoring devices market.

How do Growth Prospects Appear in the Chinese Market?

Rising Technological Advancements to propel Market Growth

The intrapartum monitoring devices market in China is poised to yield a dollar opportunity worth US$ 145.3 Million from 2022-2032, anticipated to expand at a CAGR of 6.1%. Furthermore, the country is anticipated to reach a valuation of US$ 324.0 Million by the end of the said forecast period.

China has the second-largest demand for intrapartum monitoring devices due to vast technological advancements in terms of the healthcare sector and the increasing rate of premature birth complications. Sales of intrapartum monitoring devices in the Asia Pacific market are expected to grow at a good rate.

Also, market penetration is also expected to increase during the forecast period due to an increase in the number of gynecologists, which is creating awareness in developing countries – which in turn is leading to a growth in the sales of the intrapartum monitoring market. Market incumbents are focusing on innovative technologies to collaborate with regional players to further expand their market footprint.

Is Japan likely to emerge as an Opportunistic Intrapartum Monitoring Devices Industry?

Early Adoption of Modern Health Technology and strong Infrastructure to Boost Growth

The intrapartum monitoring devices market in Japan is poised to yield a dollar opportunity worth US$ 103.7 Million from 2022-2032, anticipated to expand at a CAGR of 5.2%. Furthermore, the country is anticipated to reach a valuation of US$ 261.3 Million by the end of the said forecast period.

Japan is the other major region with significant growth prospects for the Intrapartum Monitoring Devices market. key trends and opportunities, helping the healthcare workers and patients through the integration of artificial intelligence and machine learning. Increasing R&D activities in the region will positively impact the market.

Country-wise Forecast CAGRs in the Intrapartum Monitoring Devices Market

Country	CAGR
U.S	6.6%
U.K	5.5%
China	6.1%
Japan	5.2%
South Korea	4.7%

Region-wise Insights

Which region accounts for Maximum Intrapartum Monitoring Devices Market Growth?

North America accounts for the top region in the intrapartum monitoring devices market

On the basis of region, the North America segment accounts for the highest CAGR of 7.0% through the forecast period. The ongoing technological advancements in the field of healthcare and increasing awareness and government initiatives to deliver improved maternal care solutions is driving the intrapartum monitoring devices market growth in North America.

Category-wise Insights

Which is to be the top product segment in the intrapartum monitoring devices market?

Electrodes to be a top Growth Driver

According to Fact.MR, electrodes are likely to remain the top product category, growing at a value CAGR of 5.9% from 2022-2032. The electrodes are further segmented into fetal scalp electrodes, an intrauterine pressure catheter, a transducer for Fetal Heart Rate, and a transducer for uterine contractions.

Demand is increasing due to their higher purchase volumes and increasing cases of preterm birth, and increasing diabetes cases in women. Thus the increasing cases of gestational diabetes mellitus lead to high demand for these monitoring devices and are expected to drive the market in the forecast period. On the other hand, the monitors segment is expected to exhibit the fastest growth rate over the forecast period.

Competitive Landscape :

The global market for Intrapartum Monitoring Devices is characterized by the presence of multiple vendors, aiming to offer extensive consulting and integration services to clients. Additionally, enterprises are seeking out, specialized service providers, offering solutions tailor-made to suit their business objectives. In addition, the vendors are likely to leverage up-gradation and product differentiation to gain an edge over other competitors in the market.

• In March 2021 – CooperSurgical announced the acquisition of Safe Obstetric Systems, inventor of the patented single-use device, the Fetal Pillow®. The Fetal Pillow is designed to elevate a deeply impacted fetal head without injury during a fully dilated C-section (CSFD). With elevated rates of maternal morbidity and mortality, there is an increased focus on reducing maternal and fetal complications during delivery. In technically challenging clinical situations such as CSFD, the use of the Fetal Pillow may reduce maternal blood transfusion.
• In April 2022 Royal Philips and Oulu University Hospital (Finland) announced a strategic partnership agreement to support the hospital’s ambitious OYS2030 renewal program. The program aims to transform the operations and facilities of Oulu University Hospital to meet the challenges of future specialized care. Philips is providing its latest image-guided therapy solutions and innovations to transform the diagnosis and treatment of patients, as well as maintenance, consultancy and financing services.
• In May 2022 – GE Healthcare has an agreement with Pulsenmore, to accelerate global adoption of Pulsenmore’s homecare ultrasound solutions and will also support their goal to pursue U.S. FDA clearance and commercial expansion. GE Healthcare will also partner with Pulsenmore to distribute its products in Europe and other markets to develop ultrasound-based healthcare offerings that cater to the burgeoning homecare market.

Key Segments Covered in the Intrapartum Monitoring Devices Industry Report

• Intrapartum Monitoring Devices Market by Product :

  • Intrapartum Monitors
  • Intrapartum Electrodes
    • Fetal Scalp Electrodes
    • Intrauterine Pressure Catheters
    • Transducers for Fetal Heart Rate
    • Transducers for Uterine Contractions

• Intrapartum Monitoring Devices Market by Region :

  • North America
  • Europe
  • Asia Pacific
  • Middle East & Africa
  • Latin America